Results of an ELISPOT Proficiency Panel Conducted in 11 Laboratories Participating in International Human Immunodeficiency Virus Type 1 Vaccine Trials

No abstract is available for this paper.

• Publication year

  2005

• Venue

  AIDS Research and Human Retroviruses

• Publication date

  2005-01-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1089/aid.2005.21.68PMID 15665646
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Automating Procedures for Processing, Cryopreservation, Storage, and Manipulation of Human Peripheral Blood Mononuclear Cells

  2004cited by this paper
• A human immunodeficiency virus 1 (HIV-1) clade A vaccine in clinical trials: stimulation of HIV-specific T-cell responses by DNA and recombinant modified vaccinia virus Ankara (MVA) vaccines in humans.

  2004cited by this paper
• Statistical considerations for the design and analysis of the ELISpot assay in HIV-1 vaccine trials.

  2004cited by this paper
• Preliminary steps toward validating a clinical bioassay: A case study of the ELIspot assay

  2003cited by this paper
• Moving to human immunodeficiency virus type 1 vaccine efficacy trials: defining T cell responses as potential correlates of immunity.

  2003cited by this paper
• CD4+ and CD8+ cells in cryopreserved human PBMC maintain full functionality in cytokine ELISPOT assays.

  2003cited by this paper
• New hope for AIDS vaccine.

  2003cited by this paper
• Immunogenicity of a recombinant human immunodeficiency virus (HIV)-canarypox vaccine in HIV-seronegative Ugandan volunteers: results of the HIV Network for Prevention Trials 007 Vaccine Study.

  2003cited by this paper
• Memory T cells and vaccines.

  2003cited by this paper
• Estimation of "needs" and "probable uptake" for HIV/AIDS preventive vaccines based on possible policies and likely acceptance (a WHO/UNAIDS/IAVI study).

  2003cited by this paper
• A systematic comparison of methods to measure HIV-1 specific CD8 T cells.

  2003cited by this paper
• Enhanced T-cell immunogenicity of plasmid DNA vaccines boosted by recombinant modified vaccinia virus Ankara in humans

  2003cited by this paper
• Comparison of overlapping peptide sets for detection of antiviral CD8 and CD4 T cell responses.

  2003cited by this paper
• Ex Vivo Profiling of CD8+-T-Cell Responses to Human Cytomegalovirus Reveals Broad and Multispecific Reactivities in Healthy Virus Carriers

  2003cited by this paper
• Comprehensive Epitope Analysis of Human Immunodeficiency Virus Type 1 (HIV-1)-Specific T-Cell Responses Directed against the Entire Expressed HIV-1 Genome Demonstrate Broadly Directed Responses, but No Correlation to Viral Load

  2003cited by this paper
• HIV vaccine development: lessons from the past and promise for the future.

  2003cited by this paper
• Vaccines, vaccination, and vaccinology.

  2003cited by this paper
• The need for a global HIV vaccine enterprise. Policy forum.

  2003cited by this paper
• HIV vaccines 1983–2003

  2003cited by this paper
• Enhanced: The Need for a Global HIV Vaccine Enterprise

  2003cited by this paper
• A panel of MHC class I restricted viral peptides for use as a quality control for vaccine trial ELISPOT assays.

  2002cited by this paper
• Vaccines: New hope for an aids vaccine

  2002cited by this paper
• Opinion — vaccines: The quest for an AIDS vaccine: is the CD8+ T-cell approach feasible?

  2002cited by this paper
• Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity

  2002cited by this paper
• AIDS vaccines: On the trail of two trials

  2002cited by this paper
• Cellular immune assays for evaluation of vaccine efficacy in developing countries

  2002cited by this paper
• Disappointing Data Scuttle Plans for Large-Scale AIDS Vaccine Trial

  2002cited by this paper
• The ELISPOT Assay: An Easily Transferable Method for Measuring Cellular Responses and Identifying T Cell Epitopes

  2002cited by this paper
• Design and Validation of an Enzyme-Linked Immunospot Assay for Use in Clinical Trials of Candidate HIV Vaccines

  2002cited by this paper
• Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccine.

  2002cited by this paper
• HIV vaccines: Biological and clinical considerations

  2002cited by this paper
• Toward Improved Evaluation of Cytotoxic T-Lymphocyte (CTL)-Inducing HIV Vaccines in Thailand

  2002cited by this paper
• Assays for monitoring cellular immune responses to active immunotherapy of cancer.

  2001cited by this paper
• Control of a Mucosal Challenge and Prevention of AIDS by a Multiprotein DNA/MVA Vaccine

  2001cited by this paper
• Unique T Cell Effector Functions Elicited by Plasmodium falciparum Epitopes in Malaria-Exposed Africans Tested by Three T Cell Assays1

  2001cited by this paper
• Evaluation of canarypox-induced CD8(+) responses following immunization by measuring the effector population IFNgamma production.

  2001cited by this paper
• Development and Validation of a Gamma Interferon ELISPOT Assay for Quantitation of Cellular Immune Responses to Varicella-Zoster Virus

  2001cited by this paper
• Safety and immunogenicity of a canarypox-vectored human immunodeficiency virus Type 1 vaccine with or without gp120: a phase 2 study in higher- and lower-risk volunteers.

  2001cited by this paper
• Reduction of Simian-Human Immunodeficiency Virus 89.6P Viremia in Rhesus Monkeys by Recombinant Modified Vaccinia Virus Ankara Vaccination

  2001cited by this paper
• A canarypox vector-expressing cytomegalovirus (CMV) phosphoprotein 65 induces long-lasting cytotoxic T cell responses in human CMV-seronegative subjects.

  2001cited by this paper
• UK NEQAS for leucocyte immunophenotyping: the first 10 years

  2001cited by this paper
• Application of the Intracellular Gamma Interferon Assay To Recalculate the Potency of CD8+ T-Cell Responses to Herpes Simplex Virus

  2000cited by this paper
• Vaccination of seronegative volunteers with a human immunodeficiency virus type 1 env/rev DNA vaccine induces antigen-specific proliferation and lymphocyte production of beta-chemokines.

  2000cited by this paper
• HIV-Specific CD4+ and CD8+ Immune Responses Are Generated with a gp120-Depleted, Whole-Killed HIV-1 Immunogen with CpG Immunostimulatory Sequences of DNA

  2000cited by this paper
• Viability and Functional Activity of Cryopreserved Mononuclear Cells

  2000cited by this paper
• Immunologic Monitoring of Clinical Trials in Patients with Cancer: Technology Versus Common Sense

  2000cited by this paper
• Multiepitopic B- and T-Cell Responses Induced in Humans by a Human Immunodeficiency Virus Type 1 Lipopeptide Vaccine

  2000cited by this paper
• Quantitation of antigen-reactive T cells in peripheral blood by IFNgamma-ELISPOT assay and chromium-release assay: a four-centre comparative trial.

  2000cited by this paper
• Multiple Comparisons and Multiple Tests Using the SAS System

  1999cited by this paper
• A canarypox vaccine expressing multiple human immunodeficiency virus type 1 genes given alone or with rgp120 elicits broad and durable CD8+ cytotoxic T lymphocyte responses in seronegative volunteers.

  1999cited by this paper
• Viability and Recovery of Peripheral Blood Mononuclear Cells Cryopreserved for up to 12 Years in a Multicenter Study

  1999cited by this paper
• Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes.

  1999cited by this paper
• Dramatic Rise in Plasma Viremia after CD8+ T Cell Depletion in Simian Immunodeficiency Virus–infected Macaques

  1999cited by this paper
• Quantification of CD8+ T lymphocytes responsive to human immunodeficiency virus (HIV) peptide antigens in HIV-infected patients and seronegative persons at high risk for recent HIV exposure.

  1998cited by this paper
• A New Look at T Cells

  1998cited by this paper
• Measuring human T-lymphocyte function

  1998cited by this paper
• Computer-assisted, quantitative cytokine enzyme-linked immunospot analysis of human immune effector cell function.

  1997cited by this paper
• The use of computer-assisted video image analysis for the quantification of CD8+ T lymphocytes producing tumor necrosis factor alpha spots in response to peptide antigens.

  1997cited by this paper
• Collaborative study for the evaluation of enzyme-linked immunosorbent assays used to measure human antibodies to Bordetella pertussis antigens

  1996cited by this paper
• Interlaboratory study evaluating quantitation of antibodies to Haemophilus influenzae type b polysaccharide by enzyme-linked immunosorbent assay

  1996cited by this paper
• Recognition of the highly conserved YMDD region in the human immunodeficiency virus type 1 reverse transcriptase by HLA-A2-restricted cytotoxic T lymphocytes from an asymptomatic long-term nonprogressor.

  1996cited by this paper
• HIV-specific cytotoxic T-cells in HIV-exposed but uninfected Gambian women

  1995cited by this paper
• Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome

  1994cited by this paper
• Multicenter comparison of Neisseria meningitidis serogroup C anti-capsular polysaccharide antibody levels measured by a standardized enzyme-linked immunosorbent assay

  1994cited by this paper
• Assessment of Interlaboratory Variability of Immunophenotyping

  1993cited by this paper
• Assessment of interlaboratory variability of immunophenotyping. Results of the College of American Pathologists Flow Cytometry Survey.

  1993cited by this paper
• Resampling-Based Multiple Testing: Examples and Methods for p-Value Adjustment

  1993cited by this paper
• Reverse ELISPOT assay for clonal analysis of cytokine production. I. Enumeration of gamma-interferon-secreting cells.

  1988cited by this paper
• Dramatic Rise in Plasma Viremia after Cd8 Ϩ T Cell Depletion in Simian Immunodeficiency Virus–infected Macaques

  year unknowncited by this paper

• Integration of artificial intelligence in clinical laboratory medicine: Advancements and challenges

  2024cites this paper
• Fresh or frozen grafts for allogeneic stem cell transplantation: conceptual considerations and a survey on the practice during the COVID-19 pandemic from the EBMT Infectious Diseases Working Party (IDWP) and Cellular Therapy & Immunobiology Working Party (CTIWP)

  2023cites this paper
• Recommendations on ELISpot assay validation by the GCC.

  2022cites this paper
• Harmonization and qualification of an IFN-γ Enzyme-Linked ImmunoSpot assay (ELISPOT) to measure influenza-specific cell-mediated immunity within the FLUCOP consortium

  2022cites this paper
• Detection of Cytokine-Secreting Cells by Enzyme-Linked Immunospot (ELISpot).

  2021cites this paper
• Cryopreservation Preserves Cell-Type Composition and Gene Expression Profiles in Bone Marrow Aspirates From Multiple Myeloma Patients

  2021cites this paper
• Performance of International AIDS Vaccine Initiative African clinical research laboratories in standardised ELISpot and peripheral blood mononuclear cell processing in support of HIV vaccine clinical trials

  2021cites this paper
• Flow Cytometry in Cancer Immunotherapy: Applications, Quality Assurance, and Future

  2020cites this paper
• Adhering to adhesion: assessing integrin conformation to monitor T cells

  2019cites this paper
• Handbook of ELISPOT

  2018cites this paper
• Mastering the Computational Challenges of Elispot Plate Evaluation.

  2018cites this paper
• High background in ELISpot assays is associated with elevated levels of immune activation in HIV‐1‐seronegative individuals in Nairobi

  2018cites this paper
• Performance of an IAVI-African Network of Clinical Research Laboratories in Standardized ELISpot and Peripheral Blood Mononuclear Cell Processing in Support of HIV Vaccine Clinical Trials

  2018cites this paper
• Design, development and experimental trialof a tailored cytotoxic T-cell vaccine againstPorcine Reproductive and RespiratorySyndrome Virus-2

  2017influential citation
• Improving the value of clinical research through the use of Common Data Elements

  2016cites this paper
• A simple tube adapter to expedite and automate thawing of viably frozen cells.

  2016cites this paper
• Guidelines for the automated evaluation of Elispot assays

  2015influential citation
• Generation of tumor‐specific cytotoxic T‐lymphocytes from the peripheral blood of colorectal cancer patients for adoptive T‐cell transfer

  2015cites this paper
• Establishment and maintenance of a PBMC repository for functional cellular studies in support of clinical vaccine trials.

  2014cites this paper
• Statistical methods for the assessment of EQAPOL proficiency testing: ELISpot, Luminex, and Flow Cytometry.

  2014cites this paper
• Effect of cryopreservation of peripheral blood mononuclear cells (PBMCs) on the variability of an antigen-specific memory B cell ELISpot

  2014cites this paper
• The External Quality Assurance Oversight Laboratory (EQAPOL) proficiency program for IFN-gamma enzyme-linked immunospot (IFN-γ ELISpot) assay.

  2014cites this paper
• Dominant CD4‐dependent RNA‐dependent RNA polymerase‐specific T‐cell responses in children acutely infected with human enterovirus 71 and healthy adult controls

  2014cites this paper
• Loss of long term protection with the inclusion of HIV pol to a DNA vaccine encoding gag.

  2014cites this paper
• The Center for HIV/AIDS Vaccine Immunology (CHAVI) multi-site quality assurance program for cryopreserved human peripheral blood mononuclear cells.

  2014cites this paper
• Harmonisation of short-term in vitro culture for the expansion of antigen-specific CD8+ T cells with detection by ELISPOT and HLA-multimer staining

  2014cites this paper
• Continentsin Laboratories from Three Cell and Enzyme-Linked Immunospot Trials by Peripheral Blood Mononuclear Immunodeficiency Virus Vaccine Clinical T-Cell Immunity in Human Concordant Proficiency in Measurement of

  2014cites this paper
• Characterisation of T cells induced by candidate conserved region HIV-1 vaccines in healthy HIV-1/2 negative volunteers

  2014cites this paper
• Stepping up ELISpot: Multi-Level Analysis in FluoroSpot Assays

  2014cites this paper
• Enumeration and Characterization of Human Memory T Cells by Enzyme-Linked Immunospot Assays

  2013cites this paper
• Immunological assessment of influenza vaccines and immune correlates of protection

  2013cites this paper
• Immunological Monitoring to Rationally Guide AAV Gene Therapy

  2013cites this paper
• Defining ELISpot cut-offs from unreplicated test and control wells

  2013cites this paper
• Characterization of Transcription Factor Phenotypes within Antigen-Specific CD4+ T Cells Using Qualitative Multiplex Single-Cell RT-PCR

  2013influential citation
• Issues in Pre-clinical Models, Clinical Trial Design and Analytical Considerations in Developing and Evaluating Novel Cancer Immunotherapies

  2013cites this paper
• GENERATION OF TUMOR-SPECIFIC CYTOTOXIC T-LYMPHOCYTES FROM PERIPHERAL BLOOD OF COLORECTAL CANCER PATIENTS FOR ADOPTIVE T-CELL TRANSFER

  2013cites this paper
• The impact of harmonization on ELISPOT assay performance.

  2012cites this paper
• Response determination criteria for ELISPOT: toward a standard that can be applied across laboratories.

  2012cites this paper
• Hepatitis C virus nonstructural protein specific T cells are associated with virological responses to combination therapy in chronic HCV patients

  2012cites this paper
• A Phase I Double Blind, Placebo-Controlled, Randomized Study of a Multigenic HIV-1 Adenovirus Subtype 35 Vector Vaccine in Healthy Uninfected Adults

  2012cites this paper
• Optimal Thawing of Cryopreserved Peripheral Blood Mononuclear Cells for Use in High-Throughput Human Immune Monitoring Studies

  2012cites this paper
• Therapeutic Cancer Vaccines in Prostate Cancer: The Quest for Intermediate Markers of Response

  2012cites this paper
• Therapeutic Cancer Vaccines: The Latest Advancement in Targeted Therapy

  2012cites this paper
• Immune Monitoring Design within the Developmental Pipeline for an Immunotherapeutic or Preventive Vaccine

  2012cites this paper
• Strategies for optimizing the clinical impact of immunotherapeutic agents such as sipuleucel-T in prostate cancer.

  2012cites this paper
• A critical assessment for the value of markers to gate-out undesired events in HLA-peptide multimer staining protocols

  2011cites this paper
• Antigen‐specific T cell responses to BK polyomavirus antigens identify functional anti‐viral immunity and may help to guide immunosuppression following renal transplantation

  2011cites this paper
• Sources of diversity in T cell epitope discovery.

  2011cites this paper
• Immunotherapy in prostate cancer: emerging strategies against a formidable foe.

  2011cites this paper
• T-cell immune monitoring assays to guide the development of new cancer vaccines

  2011cites this paper
• Quality assurance of intracellular cytokine staining assays: analysis of multiple rounds of proficiency testing.

  2011influential citation
• T Cell Responses of HIV-Infected Children after Administration of Inactivated or Live Attenuated Influenza Vaccines

  2010cites this paper
• Training in immunology of relevance to global health issues in resource poor settings

  2010cites this paper
• Serum is not required for ex vivo IFN-γ ELISPOT: a collaborative study of different protocols from the European CIMT Immunoguiding Program

  2010cites this paper
• Equivalence of ELISpot Assays Demonstrated between Major HIV Network Laboratories

  2010cites this paper
• Response definition criteria for ELISPOT assays revisited

  2010cites this paper
• The current and emerging role of immunotherapy in prostate cancer.

  2010cites this paper
• Evaluation and Recommendations on Good Clinical Laboratory Practice Guidelines for Phase I–III Clinical Trials

  2009cites this paper
• The role of IFN-γ Elispot assay in HIV vaccine research

  2009cites this paper
• ELISPOT assays provide reproducible results among different laboratories for T-cell immune monitoring—even in hands of ELISPOT-inexperienced investigators

  2009cites this paper
• Harmonization guidelines for HLA-peptide multimer assays derived from results of a large scale international proficiency panel of the Cancer Vaccine Consortium

  2009cites this paper
• Stimulated cell standards

  2009cites this paper
• Precision and linearity targets for validation of an IFNγ ELISPOT, cytokine flow cytometry, and tetramer assay using CMV peptides

  2008cites this paper
• Preliminary study on a potential panel for quality assurance of ELISPOT

  2008cites this paper
• Measuring Human Cytokines

  2008cites this paper
• Therapeutic vaccines in cancer: moving from immunomonitoring to immunoguiding

  2008cites this paper
• Concordant Proficiency in Measurement of T-Cell Immunity in Human Immunodeficiency Virus Vaccine Clinical Trials by Peripheral Blood Mononuclear Cell and Enzyme-Linked Immunospot Assays in Laboratories from Three Continents

  2008influential citation
• Detection of Pathogenic Protozoa in the Diagnostic Laboratory: Result Reproducibility, Specimen Pooling, and Competency Assessment

  2008cites this paper
• Guidelines on good clinical laboratory practice: bridging operations between research and clinical research laboratories.

  2008cites this paper
• Toward the harmonization of immune monitoring in clinical trials: Quo vadis?

  2007cites this paper
• Results and harmonization guidelines from two large-scale international Elispot proficiency panels conducted by the Cancer Vaccine Consortium (CVC/SVI)

  2007influential citation
• Peptide Impurities in Commercial Synthetic Peptides and Their Implications for Vaccine Trial Assessment

  2007cites this paper
• Laboratory expansion to large-scale international HIV preventive vaccine trials

  2007cites this paper
• Detection of HIV Vaccine-Induced Cell-Mediated Immunity in HIV-Seronegative Clinical Trial Participants Using an Optimized and Validated Enzyme-Linked Immunospot Assay

  2007cites this paper
• Evaluation of the Interlaboratory Concordance in Quantification of Human Immunodeficiency Virus-Specific T Cells with a Gamma Interferon Enzyme-Linked Immunospot Assay

  2006cites this paper
• Immune responses in the draining lymph nodes against cancer: Implications for immunotherapy

  2006cites this paper
• Measurement of cytokine release at the single cell level using the ELISPOT assay.

  2006cites this paper
• Methods for Detection of Antigen-Specific T Cells by Enzyme-Linked Immunospot Assay (ELISPOT)

  2006cites this paper
• Standardization and performance evaluation of mononuclear cell cytokine secretion assays in a multicenter study

  2006cites this paper
• Functional signatures in antiviral T-cell immunity for monitoring virus-associated diseases

  2006cites this paper
• Standardization of cytokine flow cytometry assays

  2005cites this paper
• IL-2 absorption affects IFN-gamma and IL-5, but not IL-4 producing memory T cells in double color cytokine ELISPOT assays.

  2005cites this paper
• Evaluation of Elispot assays: influence of method and operator on variability of results.

  2004cites this paper
• Automation of the Elispot Technique: Past, Present, and Future

  2004cites this paper
• Automating Procedures for Processing, Cryopreservation, Storage, and Manipulation of Human Peripheral Blood Mononuclear Cells

  2004cites this paper